Increasing Adoption Of The Electroceuticals For The Treatment Of Various Chronic Disease To Bring Profitable Opportunities For The Bioelectric Medicine Market

Bioelectric Medicine Market

 Bioelectric medicine is now coming to its mature stage as a successful stand-alone treatment for a growing number of medical conditions. It is used as a complementary therapy to improve the function of many organ systems, particularly the cardiovascular and immune systems. Specific applications include cardiopulmonary rehabilitation, respiratory management, and pediatric and adult neurological conditions such as stroke, sclerosis, and epilepsy.

The increasing use of electroceuticals for the treatment of various cardiac and neurological diseases such as Obsessive-Compulsive Disorder (OCD), dystonia, essential tremor, and epilepsy is driving the growth of the bioelectricmedicine market. The rise in the geriatric population is again increasing the prevalence of chronic disease which is also fueling the growth of the market. According to the United Nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. Growing investment in the research and development activities for developing advanced electroceuticals is further anticipated to foster the growth of the bioelectric medicine market over the forecast period.

North America is projected to gain significant growth over the forecast period and this is attributed to the high prevalence of the cardiovascular disease in the region. According to the National Center for Chronic Disease Prevention and Health Promotion, Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. About 655,000 Americans die from heart disease each year—that’s 1 in every 4 deaths.

Key Developments:

1.      In May 2019, Cala Health raised $50M ahead of the commercial launch of its bioelectric stimulation device. Cala Health is part of a new breed of companies developing therapeutics that target the body’s electric circuitry instead.

2.      In February 2020, KidneyCell LTP announced the launch of a clinical trial in Brazil utilizing bioelectric signaling controlled protein release to attempt to reverse kidney failure. The bioelectric stimulation signals will be applied non-invasively only in this study.

3.      In October 2020, Leonhardt's Launchpads Announces Receipt of Notice of Allowance of U.S. Patent for Bioelectric Stimulator for Organ Regeneration and Healing

4.      In February 2017, GE Ventures announced a strategic partnership with Northwell Health’s Feinstein Institute for Medical Research providing up to $200 million in joint funding to support the opening of a new Center for Bioelectronic Medicine (CBEM)

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more